We would love to hear your thoughts about our site and services, please take our survey here.
Rebarm, I tend to agree with you, I remember Stuart saying that the psoriasis association were all over this axisbiotix launch,obviously weren’t.
Influencers and social media,obviously not used to any affect at all, and it’s a brilliant product that’s the crying shame.
The figures are bad, the massive shame, is that this product is revolutionary, and it works, it works bloody well, i know 3 people who this works for, I’m paying for bloody 2 of them, let’s just hope Stuart was telling the truth when He said the big pharma’s are looking over our shoulders .
Oleric, that’s quite funny, I’m just hoping this isn’t going to be an opti sequel.
I take from the RNS that the talks with the multinational are just for the axisbiotix?
Obviously sales are disappointing, which is probably why the acne product is not talked about, probably needs a multinational, great product but needs money to sell it.
No news on wound care, thought we were on the verge of a deal, let’s hope Croda brings better news, Stuart could give us a little bit more information with regards to Croda.
Okay perhaps we won’t be having a fundraise, I’m just saying I wouldn’t be surprised if there was one, and it would probably have a positive impact on the share price, should of had some news by now, Croda results revealed a9 time’s improvement to the barrier of the skin, if this was us, which we all think it is, then this positive news should of been RNS
Wound care, Stuart ashman said 6 months ago that we could of had a deal, how about should of had a deal.also if you listen to Stuart’s last interview with Elrico
He sounded less than convincing when asked about the news we’re all expecting from the end of this oral health study.